PATENT CLAIM ANALYSIS

Application Number: 16174938
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "287000"]

Abstract:
The present invention relates to a method of preventing, reducing, or treating cancer in a subject, comprising administering a therapeutically effective amount of or a pharmaceutically acceptable salt, free base, hydrate, complex, or chelate (including metal chelates, such as iron, zinc and others) thereof to the subject, wherein the subject has a mutation in a DNA repair gene.

Claim (Index 10):
The method of  claim 1 , wherein the cancer is selected from the group consisting of heme cancer, colorectal cancer, ovarian cancer, breast cancer, cervical cancer, lung cancer, liver cancer, pancreatic cancer, cancer of the lymph nodes, leukemia, renal cancer, colon cancer, prostate cancer, brain cancer, cancer of the head and neck, bone cancer, carcinoma of the larynx and oral cavity, Ewing's sarcoma, skin cancer, kidney cancer, and cancer of the heart.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.44898
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15514043', '15112768', '15254738', '15254716', '13487979']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8040718983088281
- 35 USC 102 Novelty (BERT): 0.506167951173299
- Combined Prediction Score: 0.7742815035952751
- Mean Citation Score: 246.748466
- Max Citation Score: 251.48032
- Similarity Product: 164.20549613052367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test